ADC Therapeutics (ADCT) Total Debt: 2021-2022
Historic Total Debt for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2022 value amounting to $122.2 million.
- ADC Therapeutics' Total Debt rose 1.01% to $97,707 in Q3 2023 from the same period last year, while for Sep 2023 it was $122.5 million, marking a year-over-year decrease of 57.06%. This contributed to the annual value of $122.2 million for FY2022, which is 30.36% up from last year.
- As of FY2022, ADC Therapeutics' Total Debt stood at $122.2 million, which was up 30.36% from $93.7 million recorded in FY2021.
- ADC Therapeutics' 5-year Total Debt high stood at $122.2 million for FY2022, and its period low was $93.7 million during FY2021.
- Moreover, its 2-year median value for Total Debt was $108.0 million (2021), whereas its average is $108.0 million.
- Data for ADC Therapeutics' Total Debt shows a peak YoY spiked of 30.36% (in 2022) over the last 5 years.
- ADC Therapeutics' Total Debt (Yearly) stood at $93.7 million in 2021, then surged by 30.36% to $122.2 million in 2022.